Philip Leung
Partner,
Profilo di Philip
Competenze
Phil Leung is the leader of our Asia-Pacific Mergers & Acquisitions practice and heads up the firm's Greater China Healthcare & Life Sciences practice. He is also an active contributor to Bain's Consumer Products, Retail and Financial Services practices.
Phil is a trusted advisor to a wide range of multinational and local companies. Since joining Bain in 1996, he has worked extensively on growth strategy, transformation programs, M&A and joint ventures in Greater China and throughout Asia-Pacific. In addition to his work with clients, Phil has also led the internal development of Bain's perspectives on mergers and acquisitions, including a global study on joint ventures.
Phil has authored many articles published in international and local media outlets and his views on the M&A landscape in Asia have been widely quoted.
Phil earned his MBA from Harvard University and graduated with an undergraduate degree in business administration, with highest honors, from University of California at Berkeley.
Recent Insights
- “How M&A and Divestitures Helped Asia’s Conglomerates,” M&A Report, febbraio 2021, Report
- “Learning from Japan’s Disappointing M&A Boom,” Brief, aprile 2020
- “Philip Leung: China Outbound M&A ,” Video, dicembre 2018
- “More Rigor Means Better Results in China’s Global Pursuit,” Brief, ottobre 2018
- “The Secrets to Successful Joint Ventures,” Forbes.com, aprile 2017, Article
In the News
- “Foreign asset managers are eyeing China’s vast pool of savings,” The Economist, giugno 2021, Private Equity
- “Foreign asset managers are eyeing China’s vast pool of savings,” The Economist, giugno 2021, Private Equity
- “Chinese firms may face more competition for overseas deals,” South China Morning Post, ottobre 2018
- “China FDA's Sovaldi nod could usher in more fast track approvals,” S&P Global, settembre 2017, Aziende Farmaceutiche
- “Seven steps that can spell cross-border M&A success for Chinese companies,” South China Morning Post, ottobre 2016